Ocular Defects in Thalidomide Babies.

نویسنده

  • J F CULLEN
چکیده

IN the early reports on congenital abnormalities in thalidomide babies in Great Britain little attention has been paid to the occurrence of ocular defects. A recent survey by the Chief Medical Officer of the Ministry of Health relating to children born with congenital limb deformities during 1960-62, revealed that there were 652 surviving children with such deformities, 244 of whose mothers had definitely or possibly taken thalidomide during pregnancy. Of the children born to these 244 mothers, 146 had gross deformities or absence of two, three, or four limbs, and these included 27 with additional deformities, two-thirds of which affected the eyes or ears or both. Of the remainder 45 had deformities of one limb only, and a further 53 had minor deformities of the hands or feet or both. Gilkes and Strode (1963) have reported on the ocular findings in twenty children with limb deformities of the thalidomide type at Chailey Heritage, Sussex, and they discovered colobomatous defects in five of them. A colobomatous defect is the typical eye deformity to be expected in thalidomide children and can easily be missed unless specifically looked for. In Edinburgh, in the Summer of 1962, a thalidomide baby (Case 1) was found to have ocular defects. Since then, through the courtesy of Mr. D. W. Lamb, a further eleven thalidomide babies, three males and eight females, who attend a special clinic at the Princess Margaret Rose Orthopaedic Hospital, Edinburgh, have been examined and we have found typical colobomatous defects in two of these, giving a total of three such deformities in twelve children, again an incidence of 25 per cent.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

"The legacy of thalidomide" - A multidisciplinary meeting held at the University of York, United Kingdom, on September 30, 2016.

BACKGROUND Between 1957 and 1962 thalidomide was used as a nonaddictive, nonbarbiturate sedative that also was successful in relieving the symptoms of morning sickness in early pregnancy. Infamously, thousands of babies were subsequently born with severe birth defects. The drug is used again, today, to successfully treat leprosy, and tragically, there is a new generation of thalidomide damaged ...

متن کامل

New cases of thalidomide embryopathy in Brazil.

Thalidomide is the best known human teratogen. Although withdrawn from the market in 1961, thalidomide was remarketed after 1965 in several countries, for the treatment of erythema nodosum leprosum. Thalidomide has a potent immunomodulatory property and has now a number of approved and off-label uses in dermatologic, oncologic, infectious and gastrointestinal conditions. In the U.S., FDA approv...

متن کامل

Recognition of thalidomide defects.

Thalidomide: a brief history Thalidomide (alpha-phthalimido-glutarimide) was developed by the German firm Chemie Grunenthal as an anticonvulsant drug. Early trials showed it to be unsuitable for this purpose but indicated that it had sedative properties. Furthermore, it had one remarkable property: overdoses simply caused prolonged sleep, not death. The drug was first marketed in Germany in 195...

متن کامل

Epidemiological Surveillance of Birth Defects Compatible with Thalidomide Embryopathy in Brazil

The thalidomide tragedy of the 1960s resulted in thousands of children being born with severe limb reduction defects (LRD), among other malformations. In Brazil, there are still babies born with thalidomide embryopathy (TE) because of leprosy prevalence, availability of thalidomide, and deficiencies in the control of drug dispensation. Our objective was to implement a system of proactive survei...

متن کامل

Clinical use and control of the dispensing of thalidomide in Brasilia-Federal District, Brazil, from 2001 to 2012.

The use of thalidomide was never discontinued in Brazil where it is prescribed for leprosy type 2 reaction. Babies with birth defects compatible with the thalidomide embryopathy phenotype were born after 1965, an indication that control on drug dispensing and use failed in the country. The article reports data on thalidomide dispensing and clinical uses in the Federal District in 2011/12, when ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The British journal of ophthalmology

دوره 48  شماره 

صفحات  -

تاریخ انتشار 1964